Image pharmaphorum Editor News Wellcome Trust awards $8m cash injection to trial schizophre... The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials. News Tesaro stock rockets as rumours of Roche takeover abound Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it. News NICE says 'no' to Roche's Perjeta after breast cancer surger... NICE consulting on first draft decision News Roche to buy rest of genetics firm Foundation Medicine Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for $2.4 billion. Load more results
News Wellcome Trust awards $8m cash injection to trial schizophre... The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials.
News Tesaro stock rockets as rumours of Roche takeover abound Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it.
News NICE says 'no' to Roche's Perjeta after breast cancer surger... NICE consulting on first draft decision
News Roche to buy rest of genetics firm Foundation Medicine Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for $2.4 billion.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
